It was reported that there was an issue with the product no188z - as univation xf femur cemented f4 lm.According to the complaint description, the revision was performed due to postoperative aseptic loosening of the components.Revison surgery was required and was performed in 2022.According to manufacturer's reporting evaluation in accordance with 21 cfr 803, this event is considered reportable for the following reason: - serious injury (report not later than 30 days).The assessment for the reportability of this adverse event was based on patient harm, revison surgery.Additional information was not provided nor available.Additional patient information is not available.The adverse event is filed under aag reference (b)(4).
|
Additional information: recall class 2 with the external fda reference number (b)(4) and internal number fsca 250 + 251 was initiated 03/2021 and completed 04/2022.Investigation results: as of the date of this report the complaint products were not provided for investigation.The investigation was based upon analysis of historical data review and device history records.Batch history review: the device quality and manufacturing history records have been checked for all leading device(s) lot numbers and the products found to be according to our specification valid at the time of production.There are no similar complaints against the same lot number.According to manufacturer's reporting evaluation in accordance with 21 cfr part 803, section 803.3, this event is considered reportable for the following reason - adverse event (not later than 30 days).The assessment for the reportability of this adverse event was based on the patient harm, revision.Conclusion/preventive measures: based upon the investigation results a clear root cause conclusion cannot be drawn.There is no indication for a material-, manufacturing- or design-related failure.In the event that the complaint product will be provided for investigation in the future, an update of this report will be provided unsolicited.Based upon investigation results an internal review had been initiated.Any action regarding capa will be addressed with this case.A product recall was initiated in beginning of 2021.The devices were not marketed any longer.
|